Aarey Drugs & Pharmaceuticals shareholders and shareholding pattern
NSE: AAREYDRUGSBSE: 524412Pharmaceuticals & BiotechnologySmall Cap
Last close ₹106.73down ₹3.68 (3.33%)BSE ₹105.95
Share price at the NSE close on 23 Oct 2026. Previous close ₹110.41.
52-week range of traded prices to 23 Oct 2026
₹50.31Low, 30 Mar 2026₹114.80High, 19 Oct 2026
- Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹340 Cr2,366th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 1.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 0.33
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,92,24274.3% delivered
Who owns Aarey Drugs & Pharmaceuticals, filing by filing
Per cent of the company's shares. The last ten years of filings, from Dec 2016; the latest is the filing for Sep 2026.
Sep 2026 filing
- Promoters41.45%
- Foreign institutions4.27%
- Indian institutions1.44%
- Individuals and others52.83%
Shareholding pattern, per cent, from Sep 2022
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Dec 2016Filed 12 Jan | Mar 2017Filed 20 Apr | Jun 2017Filed 19 Jul | Sep 2017Filed 17 Oct | Dec 2017Filed 1 Feb | Mar 2018Filed 19 Apr | Jun 2018Filed 21 Jul | Sep 2018Filed 16 Oct | Dec 2018Filed 21 Jan | Mar 2019Filed 21 Apr | Jun 2019Filed 16 Jul | Sep 2019Filed 14 Oct | Dec 2019Filed 3 Feb | Mar 2020Filed 9 Jun | Jun 2020Filed 9 Jul | Sep 2020Filed 6 Nov | Dec 2020Filed 8 Jan | Mar 2021Filed 3 May | Jun 2021Filed 13 Jul | Sep 2021Filed 8 Oct | Dec 2021Filed 6 Jan | Mar 2022Filed 11 Apr | Jun 2022Filed 14 Jul | Sep 2022Filed 19 Oct | Dec 2022Filed 16 Jan | Mar 2023Filed 20 Apr | Jun 2023Filed 21 Jul | Sep 2023Filed 13 Oct | Dec 2023Filed 12 Jan | Mar 2024Filed 12 Apr | Jun 2024Filed 17 Jul | Sep 2024Filed 11 Oct | Dec 2024Filed 13 Jan | Mar 2025Filed 19 Apr | Jun 2025Filed 21 Jul | Sep 2025Filed 20 Oct | Dec 2025Filed 20 Jan | Mar 2026Filed 20 Apr | Jun 2026Filed 21 Jul | Sep 2026Filed 21 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.94% | 53.40% | 53.40% | 58.04% | 58.05% | 49.86% | 49.86% | 49.85% | 50.44% | 50.44% | 50.44% | 50.77% | 51.00% | 49.38% | 49.38% | 49.38% | 49.38% | 49.38% | 49.38% | 49.38% | 48.05% | 48.06% | 50.03% | 50.03% | 50.03% | 50.04% | 50.04% | 50.04% | 50.04% | 45.28% | 45.28% | 45.44% | 44.80% | 44.80% | 44.80% | 44.80% | 39.06% | 37.71% | 37.71% | 41.45% | |
| Indian promoters | 54.94% | 53.40% | 53.40% | 58.04% | 58.05% | 49.86% | 49.86% | 49.85% | 50.44% | 50.44% | 50.44% | 50.77% | 51.00% | 49.38% | 49.38% | 49.38% | 49.38% | 49.38% | 49.38% | 49.38% | 48.05% | 48.06% | 50.03% | 50.03% | 50.03% | 50.04% | 50.04% | 50.04% | 50.04% | 45.28% | 45.28% | 45.44% | 44.80% | 44.80% | 44.80% | 44.80% | 39.06% | 37.71% | 37.71% | 41.45% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. | 45.06% | 46.60% | 46.60% | 41.96% | 41.95% | 50.14% | 50.14% | 50.15% | 49.56% | 49.56% | 49.56% | 49.23% | 49.00% | 50.62% | 50.62% | 50.62% | 50.62% | 50.62% | 50.62% | 50.62% | 51.95% | 51.94% | 49.97% | 49.97% | 49.97% | 49.96% | 49.96% | 49.96% | 49.96% | 54.72% | 54.72% | 54.56% | 55.20% | 55.20% | 55.20% | 55.20% | 60.94% | 62.29% | 62.29% | 58.55% |
| Shares in issue | 1,75,79,684 | 1,80,84,684 | 1,80,84,684 | 2,00,84,684 | 2,00,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,33,84,684 | 2,53,84,684 | 2,53,84,684 | 2,53,84,684 | 2,53,84,684 | 2,53,84,684 | 2,53,84,684 | 2,53,84,684 | 2,53,84,684 | 2,53,84,684 | 2,80,54,303 | 2,80,54,303 | 2,79,54,303 | 2,83,54,303 | 2,83,54,303 | 2,83,54,303 | 2,83,54,303 | 2,83,54,303 | 2,83,54,303 | 2,83,54,303 | 3,18,74,303 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. | 41,25,000 | 33,60,000 | 12,70,000 | – | – | 58,65,000 | 53,60,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 8,00,000 | – | 87,60,834 | 94,60,834 | 94,60,834 | 1,07,60,834 | 1,08,49,946 | 20,00,000 | 98,63,584 | 98,63,584 | 98,63,584 | 1,27,02,443 | 1,31,67,860 | 37,85,036 | 11,18,695 | 36,88,314 | 1,61,41,257 | 1,31,02,943 | 1,31,02,943 | – | – | – | – |
| Promoters' shares locked in | 33,60,000 | 33,60,000 | 0 | – | – | 53,60,000 | 53,60,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 20,00,000 | 8,00,000 | – | 87,10,834 | 93,60,834 | 93,60,834 | 93,60,834 | 93,60,834 | 6,50,000 | 98,63,584 | 98,63,584 | 98,63,584 | 1,27,02,443 | 1,27,02,443 | 6,50,000 | 6,50,000 | 6,50,000 | 1,27,02,443 | 1,27,02,443 | 1,27,02,443 | – | – | – | – |
Filings before Sep 2022 are on an older form, which did not split institutions into foreign and Indian and grouped some holders differently, so those columns show only the lines both forms state alike. A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Aarey Drugs & Pharmaceuticals promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is Bina Rajesh Ghatalia, 14.13%. The filing names 3 more members with no shares.Promoter buying and selling
| Holder | ||
|---|---|---|
| Bina Rajesh GhataliaIndividuals and Hindu undivided families | 14.13% | 45,03,584 |
| Mihir Rajesh GhataliaIndividuals and Hindu undivided families | 9.98% | 31,80,888 |
| Nimit ImpexIndian companies, trusts and others | 6.31% | 20,10,000 |
| Nimit Rajesh GhataliaIndividuals and Hindu undivided families | 5.18% | 16,50,000 |
| Mira Mihir GhataliaIndividuals and Hindu undivided families | 2.95% | 9,40,000 |
| Ekta Nimit GhataliaIndividuals and Hindu undivided families | 1.57% | 5,00,000 |
| MIHIR RAJESH GHATALIA HUFIndividuals and Hindu undivided families | 0.77% | 2,45,000 |
| Rajesh Pranlal GhataliaIndividuals and Hindu undivided families | 0.57% | 1,82,971 |
No promoter shares are reported as pledged.
Largest public holders of Aarey Drugs & Pharmaceuticals, filing by filing
Per cent, on the same shares as the split above.
| Holder | Dec 2016Filed 12 Jan | Mar 2017Filed 20 Apr | Jun 2017Filed 19 Jul | Sep 2017Filed 17 Oct | Dec 2017Filed 1 Feb | Mar 2018Filed 19 Apr | Jun 2018Filed 21 Jul | Sep 2018Filed 16 Oct | Dec 2018Filed 21 Jan | Mar 2019Filed 21 Apr | Jun 2019Filed 16 Jul | Sep 2019Filed 14 Oct | Dec 2019Filed 3 Feb | Mar 2020Filed 9 Jun | Jun 2020Filed 9 Jul | Sep 2020Filed 6 Nov | Dec 2020Filed 8 Jan | Mar 2021Filed 3 May | Jun 2021Filed 13 Jul | Sep 2021Filed 8 Oct | Dec 2021Filed 6 Jan | Mar 2022Filed 11 Apr | Jun 2022Filed 14 Jul | Sep 2022Filed 19 Oct | Dec 2022Filed 16 Jan | Mar 2023Filed 20 Apr | Jun 2023Filed 21 Jul | Sep 2023Filed 13 Oct | Dec 2023Filed 12 Jan | Mar 2024Filed 12 Apr | Jun 2024Filed 17 Jul | Sep 2024Filed 11 Oct | Dec 2024Filed 13 Jan | Mar 2025Filed 19 Apr | Jun 2025Filed 21 Jul | Sep 2025Filed 20 Oct | Dec 2025Filed 20 Jan | Mar 2026Filed 20 Apr | Jun 2026Filed 21 Jul | Sep 2026Filed 21 Oct |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elysian Wealth FundForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.65% | 3.12% | 3.12% | 2.78% |
| Krishnamurthy C GResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.73% | 1.73% | 1.73% | 1.76% | 1.76% | 1.76% | 1.57% |
| Suvi Rubber Pvt LtdCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.12% | 2.12% | 1.65% | 1.47% |
| Shree Salasar Properties and Finance Private LimitedNon-bank lenders registered with RBI | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.62% | 1.62% | 1.44% |
| Chetan Kirtibhai MehtaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.18% | – | 1.18% | 1.18% | 1.18% | 1.18% | 1.18% | 1.60% | 1.60% | 1.07% | 1.59% | 1.59% | 1.59% | 1.59% | 1.59% | 1.41% | 1.41% | 1.25% |
| Richa BothraResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.26% | 1.36% | 1.21% |
| Resonance Opportunities FundForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.05% | – | 1.05% | – |
| Vijay Kumar Babulal ShahResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.06% | 1.06% | 1.06% | 1.04% | 1.04% | 1.04% | 1.04% | – |
| Kls Commodities Private LimitedCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.02% | – |
| Mvm Commodities Private LimitedCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.11% | – | – |
| Resonance Opportunity fundForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.05% | – | – |
| Nishith Atulbhai ShahResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.42% | – | – | – |
| Archana Pramod WaniResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.41% | 1.41% | 1.41% | 1.41% | – | – | – |
| India Opportunities Growth Fund Ltd - Pinewood StrategyForeign portfolio investors, category I | – | – | – | – | – | 4.81% | 4.90% | 4.90% | 4.90% | 4.90% | 4.90% | 4.90% | 4.90% | 4.90% | 3.10% | 3.21% | 3.21% | 3.21% | 3.21% | – | – | 3.92% | 3.92% | 3.92% | 3.92% | 3.92% | 3.92% | 3.92% | 3.83% | 3.40% | 3.40% | 2.67% | 2.34% | – | 1.73% | – | – | – | – | – |
| INDIA OPPORTUNITIES GROWTH FUND nLTD - PINEWOODForeign portfolio investors, category I | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 2.34% | – | – | – | – | – | – |
| Black Hawk Properties Private LimitedCompanies | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.35% | 1.35% | – | – | 1.34% | – | – | – | – | – | – |
| Zil Penil DoshiResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.48% | – | 1.48% | 1.48% | 1.48% | 1.48% | 1.48% | 1.34% | 1.34% | 1.34% | 1.32% | 1.32% | – | – | – | – | – | – |
| C G KrishnamurthyResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.83% | – | 1.83% | 1.83% | 1.83% | 1.93% | 1.93% | 1.75% | 1.75% | 1.75% | 1.73% | – | – | – | – | – | – | – |
| Vijaykumar B ShahResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.07% | 1.07% | – | – | – | – | – | – | – | – | – |
| Dinesh Kumar JainResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.14% | – | 1.38% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Narendrakumar Bhagwandas GuptaResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.07% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Aidos India Fund LtdInstitutions Foreign Portfolio Investor | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.81% | 3.81% | 3.81% | 3.70% | 3.70% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Lts Investment Fund LtdInstitutions Foreign Portfolio Investor | – | – | – | – | – | 4.70% | 4.13% | 4.13% | 4.13% | 4.13% | 4.13% | 4.13% | 4.13% | 4.13% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Elara India Opportunities Fund LimitedInstitutions Foreign Portfolio Investor | – | – | – | – | – | – | 1.08% | 1.08% | 1.08% | 1.51% | 1.51% | 1.51% | 1.51% | 1.51% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Nomura Singapore LimitedInstitutions Foreign Portfolio Investor | – | – | – | – | – | 4.70% | 4.28% | 4.28% | 4.28% | 4.28% | 4.28% | 4.28% | 3.42% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Urmila Rameshchandra MehtaResident individuals, over ₹2 lakh at face value | 1.84% | 2.38% | 2.74% | 1.74% | 1.49% | – | – | – | 1.73% | 1.91% | 2.44% | – | 2.90% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Ankur ModiResident individuals, over ₹2 lakh at face value | – | – | – | – | – | – | – | 1.15% | 1.53% | 1.60% | 1.60% | – | 1.89% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Arcadia Share &Stock Brokers Pvt LtdOther non-institutions | 2.05% | 2.02% | 1.34% | 1.01% | – | 1.02% | 1.61% | 1.39% | 1.04% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Shriram Insight Share Brokers LtdOther non-institutions | – | – | – | – | – | 1.91% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Maxgrow Fintrade Private LimitedOther non-institutions | – | – | 1.04% | 1.41% | 1.19% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| Gedalia Multitrading Private LimitedOther non-institutions | – | – | – | 1.02% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
| B N MittalOther non-institutions | – | 1.01% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.